1. Pirsch JD, Miller J, Deierhoi MH, Vincenti F, Filo RS. FK506 Kidney Transplant Study Group. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. Transplantation. 1997. 63:977–983.
2. Margreiter R. European Tacrolimus vs Ciclosporin Microemulsion Renal Transplantation Study Group. Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study. Lancet. 2002. 359:741–746.
3. Mehmet H. Caspases find a new place to hide. Nature. 2000. 403:29–30.
4. Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA, et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature. 2000. 403:98–103.
5. Morishima N, Nakanishi K, Takenouchi H, Shibata T, Yasuhiko Y. An endoplasmic reticulum stress-specific caspase cascade in apoptosis. Cytochrome c-independent activation of caspase-9 by caspase-12. J Biol Chem. 2002. 277:34287–34294.
6. Jordan ML, Naraghi R, Shapiro R, Smith D, Vivas CA, Scantlebury VP, et al. Tacrolimus rescue therapy for renal allograft rejection--five-year experience. Transplantation. 1997. 63:223–228.
7. Schleibner S, Krauss M, Wagner K, Erhard J, Christiaans M, van Hooff J, et al. FK 506 versus cyclosporin in the prevention of renal allograft rejection--European pilot study: six-week results. Transpl Int. 1995. 8:86–90.
8. Gao Z, Huang K, Xu H. Protective effects of flavonoids in the roots of Scutellaria baicalensis Georgi against hydrogen peroxide-induced oxidative stress in HS-SY5Y cells. Pharmacol Res. 2001. 43:173–178.
9. Halliwell B, Gutteridge JMC. Halliwell B, Gutteridge JMC, editors. Protection aganist oxidants in biological systems: the superoxide theory of oxygen toxicity. Free Radicals in Biology and Medicine. 1989. 2nd ed. Oxford: Clarendon Press;86–89.
10. Tenhunen R, Marver HS, Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci U S A. 1968. 61:748–755.
11. Stocker R, McDonagh AF, Glazer AN, Ames BN. Antioxidant activities of bile pigments: biliverdin and bilirubin. Methods Enzymol. 1990. 186:301–309.
12. Verma A, Hirsch DJ, Glatt CE, Ronnett GV, Snyder SH. Carbon monoxide: a putative neural messenger. Science. 1993. 259:381–384.
13. Tanaka S, Akaike T, Fang J, Beppu T, Ogawa M, Tamura F, et al. Antiapoptotic effect of haem oxygenase-1 induced by nitric oxide in experimental solid tumour. Br J Cancer. 2003. 88:902–909.
14. Kroncke KD, Fehsel K, Kolb-Bachofen V. Nitric oxide: cytotoxicity versus cytoprotection--how, why, when, and where? Nitric Oxide. 1997. 1:107–120.
15. Messmer UK, Brune B. Nitric oxide-induced apoptosis: p53-dependent and p53-independent signalling pathways. Biochem J. 1996. 319(Pt 1):299–305.
16. Gotoh T, Mori M. Nitric oxide and endoplasmic reticulum stress. Arterioscler Thromb Vasc Biol. 2006. 26:1439–1446.
17. Liu YH, Carretero OA, Cingolani OH, Liao TD, Sun Y, Xu J, et al. Role of inducible nitric oxide synthase in cardiac function and remodeling in mice with heart failure due to myocardial infarction. Am J Physiol Heart Circ Physiol. 2005. 289:H2616–H2623.
18. Xu C, Bailly-Maitre B, Reed JC. Endoplasmic reticulum stress: cell life and death decisions. J Clin Invest. 2005. 115:2656–2664.
19. Zhou J, Lhotak S, Hilditch BA, Austin RC. Activation of the unfolded protein response occurs at all stages of atherosclerotic lesion development in apolipoprotein E-deficient mice. Circulation. 2005. 111:1814–1821.